These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10069758)

  • 1. Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?
    Schulman S
    Haemostasis; 1998; 28 Suppl 3():17-21. PubMed ID: 10069758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran.
    Eriksson H
    Drugs; 2004; 64 Suppl 1():37-46. PubMed ID: 15586626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
    Raskob GE; Hirsh J
    Chest; 2003 Dec; 124(6 Suppl):379S-385S. PubMed ID: 14668421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.
    Le Maître A; Ding K; Shepherd FA; Leighl N; Arnold A; Seymour L;
    J Thorac Oncol; 2009 May; 4(5):586-94. PubMed ID: 19357539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of venous thromboembolism with low-molecular-weight heparin.
    Monreal M
    Curr Opin Pulm Med; 2000 Jul; 6(4):326-9. PubMed ID: 10912641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
    Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
    Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Svensson PJ; Själander A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):961-966. PubMed ID: 28468510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
    Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis.
    Marchetti M; Pistorio A; Barone M; Serafini S; Barosi G
    Am J Med; 2001 Aug; 111(2):130-9. PubMed ID: 11498067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
    Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
    JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis.
    Noble SI; Shelley MD; Coles B; Williams SM; Wilcock A; Johnson MJ;
    Lancet Oncol; 2008 Jun; 9(6):577-84. PubMed ID: 18510989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.